Clinical Trial

Study About Contrast Media

Recruiting
View on ClinicalTrials.gov →
Summary
Patients hospitalized with adhesive small bowel obstruction (SBO) are randomized to 2 study groups at admission after signing an informed consent form. Water-soluble contrast media (CM) will be administered after 4 or after 24 hours of nasogastric- tube decompression.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-01-03; most recent amendment 2025-03-25.
Status change: Not Yet Recruiting → Recruiting 2023-11-16
Trial Details
NCT Number NCT05678023
Lead Sponsor University of Tartu
Collaborators: North Estonia Medical Centre
Conditions Small Bowel Obstruction
Enrollment 120 participants
Start Date 2023-09-01
Primary Completion 2025-03-30 (estimated)
Study Completion 2025-08-01 (estimated)
Updated on ClinicalTrials.gov 2025-03-30